Global Overview of $94 Billion Tissue Engineering Market: Technologies and Therapeutic Areas Analysis to 2022
DUBLIN, Sept. 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8nw45m/tissue) has announced the addition of the "Tissue Engineering: Technologies and Therapeutic Areas - A Global Market Overview" report to their offering.
The markets of technologies and therapeutic applications are analyzed in terms of USD. Global market for Tissue Engineering, estimated at US$23 billion in 2015, forecast to reach US$27.3 billion in 2015, and is further expected to register a CAGR of about 23% between 2016 and 2022 to touch a projected US$94.2 billion by 2022.
The study review, analyze and projects the tissue engineering market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 5 independent countries across North America - The United States and Canada; and Europe - France, Germany and the United Kingdom.
Worldwide market for Tissue Engineering technologies explored in this study includes Cell Culture, Immunomodulation and Stem Cell. The report also focuses on therapeutic applications of tissue engineering comprising Cardiovascular, Dental/Oral Neurological, Oncology, Orthopedic, Skin/Integumentary and Others.
This market research report includes 113 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The report profiles 31 key global players and 39 major players across North America - 28; Europe - 7; Asia-Pacific - 3; and Rest of World - 1. The research also provides the listing of the companies engaged in research and development and services of tissue engineering. The global list of companies covers addresses, contact numbers and the website addresses of 300 companies.
Key Topics Covered:
Part A: Global Market Perspective
1. Introduction
2. Key Market Trends
2.1 Tissue Engineering Enters The 4D Age
2.2 Cartilage Restoration Gets A Boost With Novel Tissue Engineering Approach
2.3 3-D Designs For Neural Tissue Engineering Witnesses Advancements
2.4 Peripheral Nerve Injuries Repaired Using Tissue Engineering
2.5 Biosensor Application In Tissue Engineering Gaining Prominence
2.6 Protein Mimic Offers Potential As Glue In Tissue Engineering
2.7 3D-Printed Biopolymers In Tissue Engineering Applications
2.8 Novel Tissue Scaffold Technology Shows Promise In Rebuilding Large Organs
2.9 Co-Cultures Based On Stem Cells Foster Progression In Tissue Engineering
2.10 Rapid Growth In Use Of Collagen-Based Biomaterials For Tissue Engineering Applications
2.11 Tissue Engineering Gaining Ground In Corneal Stem Cell-Based Therapies
2.12 Tissue Engineering For Blood Vessels Making Steady Progress
2.13 Tissue Engineering Helps In Growing Leg Muscle From Cells In A Dish
2.14 Advancements In 3D Printing And Tissue Engineering Technology
2.15 Click Chemistry Finds Application In Tissue Engineering
3. Key Global Players
4. Key Business Trends
5. Global Market Overview 5.1 Global Tissue Engineering Market Overview By Technology 5.2 Global Tissue Engineering Market Overview By Application
Part B: Regional Market Perspective
1. North America
2. Europe
3. Asia-Pacific
4. Rest Of World
Part C: Guide To The Industry
Part D: Annexure
Companies Mentioned
- Acelity L.P. Inc.
- Acell Inc.
- Athersys, Inc.
- Biocomposites Ltd.
- Biotime, Inc.
- Biotissue Technologies GmbH
- C. R. Bard, Inc.
- Caladrius Biosciences, Inc.
- Cellerant Therapeutics, Inc.
- Cryolife Inc.
- Cytograft Tissue Engineering, Inc.
- Cytori Therapeutics, Inc.
- Episkin
- Gamida Cell Ltd.
- Histogenics Corporation
- Integra Lifesciences Holdings Corporation
- International Stem Cell Corporation
- Japan Tissue Engineering Co Ltd
- Koninklijke DSM NV
- Lifecord International Co Ltd
- Ocata Therapeutics, Inc
- Organogenesis Inc.
- Osiris Therapeutics, Inc.
- Piramal Enterprises Limited
- RTI Surgical, Inc.
- Stemcell Technologies Inc.
- TETEC® Tissue Engineering Technologies AG
- Taxus Cardium Pharmaceuticals Group, Inc.
- Tissue Regenix Group PLC
- Viacyte, Inc.
- Zimmer Biomet Holdings Inc.
For more information visit
http://www.researchandmarkets.com/research/8nw45m/tissue
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article